H. Lundbeck A/S (Lundbeck), a biopharmaceutical company focusing exclusively on brain health, announced positive results, meeting its primary endpoint, in the multiple IV dosing part of PROCEED, an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results